[1] Chakraborty K.; Neogi R.; Basu D. Club drugs: review of the "rave" with a note of concern for the Indian Scenario. Indian J Med Res. 2011: 594-604

[2] Andresen H.; Stimpfl T.; Sprys, N.; Schnitgerhans, T.; Müller, A.; Liquid ectasy-A significant drug problem. Deutsches Ärzteblatt International 2008: 599-603

[3] Guerreiro, D.; Carmo, A.; Silva, J.; Navarro, R.; Góis, C; Club drugs - Um Novo Perfil de Abuso de Substâncias em Adolescentes e Jovens Adultos. Acta Med Port. 2011; 24(5):739-756

[4] Snead,O.; Gibson, K.; Drug Therapy - γ-Hydroxybutyric Acid. N Engl J Med 2005;352:2721-32

[5] http://www.ff.up.pt/toxicologia/monografias/ano0910/propofol/toxicologia.html (Acedido em 17/05/2013)

[6] European Monitoring Centre for Drugs and Drug Addiction. GHB and its precursor GBL: an emerging trend case study. EMCDDA thematic papers 2008; Available from: http://www.emcdda.europa.eu/publications/thematic-papers/ghb ( Acedido em 18/05/2013)

[7] Németh, Z; Kun, B.; Demetrovics, Z.; Review: The involvement of gamma-hydroxybutyrate in reported sexual assaults: a systematic review. Journal of Psychopharmacology 2010 24(9) 1281–1287

[8] Carter, L; Potential impact of drug effects, availability, pharmacokinetics, and screening on estimates of drugs implicated in cases of assault. Drug Testing and Analysis 2011, 3, 586–593

[9] Carter, L.; Pardi, D.; Gorslinec, J.; Griffiths, R. Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem®): Differences in characteristics and misuse. Drug and Alcohol Dependence 104 (2009) 1–10

[10] Bosch O.; Quednow B.; Reconsidering GHB: Orphan or new drug model antidepressant?.Journal of Psychopharmacology 2012; 26-618
[11] http://www.justice.gov/dea/druginfo/drug_data_sheets/GHB.pdf (Acedido em 19/05/2013)

[12] http://www.indiegogo.com/projects/drug-rape-prevention-drinksavvy-color-changing-drinkware (Acedido em 20/05/2013)